MT 100

Author：  

Publisher： Adis International

ISSN： 1174-5886

Source： Drugs in R&D, Vol.4, Iss.1, 2003-01, pp. : 57-58

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Naproxen Sodium/Metoclopramide: Metoclopramide/Naproxen-Sodium, MT 100, Naproxen-Sodium/Metoclopramide

By Adis International Limited  

Drugs in R&D, Vol. 7, Iss. 4, 2006-01 ,pp. : 259-261

Adis International

Access to resources Recommend Favorite

MT 300: Dihydroergotamine Mesylate Injection - POZEN

By  

Drugs in R&D, Vol. 4, Iss. 2, 2003-01 ,pp. : 133-134

Adis International

Access to resources Recommend Favorite

MT 300 – POZEN: Dihydroergotamine Mesylate Injection

By Limited A.I.  

Drugs in R&D, Vol. 4, Iss. 6, 2003-01 ,pp. : 376-377

Adis International

Access to resources Recommend Favorite

Influence of mtDNA genetic variation on antibiotic therapy

By Pacheu-Grau David   Gómez-Durán Aurora   Montoya Julio   Ruiz-Pesini Eduardo  

Pharmacogenomics, Vol. 11, Iss. 9, 2010-09 ,pp. : 1185-1187

Future Medicine

Access to resources Recommend Favorite

Characterisation of human melatonin mt 1 and MT 2 receptors by CRE-luciferase reporter assay

By Conway S.   Canning S.J.   Howell H.E.   Mowat E.S.   Barrett P.   Drew J.E.   Delagrange P.   Lesieur D.   Morgan P.J.  

European Journal of Pharmacology, Vol. 390, Iss. 1, 2000-02 ,pp. : 15-24

Elsevier

Access to resources Recommend Favorite